Monday, December 9, 2019 Daily Archives

Agilent aims to double oligo sales as CO plant comes into play

by

Agilent Technologies says it hopes to bring in $200 million in oligonucleotide revenues as it ramps up capacity to serve the growing RNAi sector. Agilent Technologies gained a nucleic acid active pharmaceutical ingredients (API) manufacturing base in Frederick, near Boulder, Colorado, in 2006 when it acquired SynPro Corp. In 2016, the life sciences technology and services firm announced plans to double its oligonucleotide capacity through a new $120 million (€108 million) facility at the site. At the Evercore ISI HealthCONx…

December 9, 2019

$50m deal helps make Sartorius a media player again

by

A year after ending an exclusive collaboration with Lonza for cell culture media and buffers, Sartorius has reentered the space by acquiring 50% of Israeli firm Biological Industries The deal sees bioprocess equipment and consumables vendor Sartorius pay €45 million ($50 million) in cash to Kibbutz Beit Haemek and private equity fund Fortissimo Capital for just over half of Biological Industries. Under terms of the deal, Sartorius will have the option to acquire a further 20% of the Haifa, Israel-based…

December 9, 2019